1don MSN
Sana Biotechnology showcases successful in vivo gene editing of stem cells in Nature publication
Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to invest in. On December 8, Sana ...
With a Kobe University-developed procedure, induced pluripotent stem cells can now be frozen directly in their dishes without ...
Under the ongoing collaboration Remedy Cell’s personnel, along with Pluri’s Contract Development and Manufacturing Organization (“CDMO”) division (PluriCDMO™), have successfully completed the full ...
New research may offer hope for endangered species Findings offer potential for regenerative medicine field Earlier study used different method for 'bipaternal' mice Jan 28 (Reuters) - Scientists in ...
The ISSCR has selected five distinguished early career scientists to serve as new Early Career Editors for Stem Cell Reports, the peer-reviewed, open access, online journal of the International ...
Breakthrough in Intractable Intestinal Disease Treatment Using Xenogeneic-Free Intestinal Stem Cells
Intestinal Stem Cells (ISCs) derived from a patient's own cells have garnered significant attention as a new alternative for ...
News-Medical.Net on MSN
Combining stem cell therapy and BDNF enhancement to manage Parkinson’s disease
Parkinson's disease (PD) is an age-related, progressive, neurodegenerative condition, caused by loss of dopamine-producing neurons.
These factors prompted research into better and more permanent treatments for T1D. The most obvious solution: restore the natural repertoire of β cell islets. Although most recipients experienced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback